Article

Compensation of urologists, other specialists not keeping pace with inflation

Increases in urologists? overall compensation did not keep up with inflation in 2008, according to a survey by the Medical Group Management Association. The same finding held true for several other physician specialties and primary care providers.

Increases in urologists’ overall compensation did not keep up with inflation in 2008, according to a survey by the Medical Group Management Association. The same finding held true for several other physician specialties and primary care providers.

Urologists’ median compensation in 2008 was $383,016, representing a 4.97% inflation-adjusted decline from the prior year. Inflation in 2008 amounted to a 3.8% increase in the U.S. Consumer Price Index. Urologists’ compensation has been generally flat since 2004 (.09% inflation-adjusted increase), according to the survey.

Overall, specialists’ compensation rose 2.19% (–1.59% when adjusted for inflation) in 2008 to a median of $339,738. Physicians in primary care compounded a history of generally flat compensation in 2008 with a reported 2% increase (–1.73% adjusted for inflation) to a median of $186,044.

"Physician practices endure tough economic challenges to stay solvent, especially these days," said William F. Jessee, MD, MGMA president and CEO. "For physicians to have a chance to hold their incomes steady, it’s vital that they pay close attention to their bottom line and benchmark their practices and compensation levels against their peers. With physician payment rates lagging behind inflation, physician practices need as many tools as possible to maintain their incomes."

The MGMA survey also found that median collections for professional charges among urologists showed a significant 7.33% inflation-adjusted decline between 2008 and 2007. Collections were down for specialists as a whole during the period. This, according to MGMA, may signal the leading edge of the economic downturn in 2008, demonstrating the trend of patients electing to postpone care.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Woman having telemedicine appointment with doctor | Image Credit: © Jacob Lund - stock.adobe.com
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
 Nicholas Zaorsky, MD, MS: Protecting kidney function after local renal cell carcinoma therapy
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.